Mean Age – years + SD |
63.6 + 10.5 |
65.4 + 10.1 |
0.2 |
Male sex – no. (%) |
85 (76.6) |
86 (77.5) |
0.9 |
Ejection fraction – % + SD |
55.3 +
10.2 |
55.2 + 13.1 |
0.9 |
Left atrial diameter – no. + SD |
4.4 +
0.6 |
4.4 + 0.7 |
0.6 |
Mean BSA (m2) – no. + SD |
2.1 + 0.26 |
2.1 + 0.24 |
0.9 |
Mean NPAF Duration – days + SD |
546.4 +
1104.2 |
375.8 + 592 |
0.2 |
Medical history – no. (%) |
|
|
|
Hypertension |
73 (66) |
73 (66) |
1 |
Diabetes |
13 (11.7) |
17 (15.3) |
0.4 |
Coronary disease |
24 (21.6) |
30 (27) |
0.3 |
Stroke or transient ischemic attack |
11 (9.9) |
5 (4.5) |
0.1 |
Heart failure |
23 (20.7) |
26 (23.4) |
0.6 |
Baseline Medications – no. (%)
Beta-blocker
Calcium-channel blocker
Digoxin
Propafenone
Flecainide
Sotalol
Amiodarone
Dofetilide
Dronedarone
|
87 (78.4)
31 (27.9)
19 (17.1)
6 (5.4)
3 (2.7)
9 (8.1)
22 (19.8)
0 (0)
21 (18.9)
|
90 (81.1)
35 (31.5)
14 (12.6)
6 (5.4)
5 (4.5)
10 (9)
10 (9)
0 (0)
20 (18)
|
0.6
0.6
0.3
1
0.5
0.8
0.02
1
0.9
|
CHA2DS2-VASc - no. (%) |
|
|
0.3 |
0 |
14 (12.6) |
13 (11.7) |
|
1 |
29 (26.1) |
22 (19.8) |
|
2 |
23 (20.7) |
19 (17.1) |
|
> 2 |
45 (40.5) |
57 (51.4) |
|